0
Your cart

Your cart is empty

Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics

Buy Now

Pioneering Human Myoblast Genome Therapy (Paperback) Loot Price: R1,082
Discovery Miles 10 820
Pioneering Human Myoblast Genome Therapy (Paperback): Peter K. Law

Pioneering Human Myoblast Genome Therapy (Paperback)

Peter K. Law

 (sign in to rate)
Loot Price R1,082 Discovery Miles 10 820 | Repayment Terms: R101 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Human Myoblast Genome Therapy (HMGT) is a platform technology of cell transplantation, nuclear transfer, and tissue engineering. Myoblasts are differentiated, immature cells destined to become muscles. Myoblasts cultured from muscle biopsy survive, develop and function to revitalise degenerative muscles upon transplantation. Transplant injury activates regeneration of host myofibers that fuse with the injected myoblasts, sharing their nuclei in a common gene pool of the syncytium. Thus, through nuclear transfer and complementation, human genome can be transferred into muscles of genetically-ill patients to achieve phenotype repair. Myoblasts are safe and efficient universal gene transfer vehicles endogenous to muscles that constitute 50% of the body. Myoblasts fuse among themselves to form new myofibres. Patients take only 2-month cyclosporine to immunosuppress allograft rejection because myofibres do not express MHC-1 antigens. The first correction of human gene defect was published in the Lancet on July 14, 1990 when the therapeutic protein dystrophin was found in the myoblast-injected muscle of a Duchenne muscular dystrophy (DMD) patient. Results over 280 HMGT procedures on MD subjects in the past 15 years demonstrated absolute safety. Myoblast-injected DMD muscles showed improved histology. Strength increase at 18 months post-operatively averaged 123%. FDA-approved clinical trials progressed unto Phase III in USA with direct cost recovery. Heart muscle degeneration is the leading cause of human debilitation and death.

General

Imprint: nova science publishers
Country of origin: United States
Release date: May 2009
Authors: Peter K. Law
Dimensions: 155 x 230 x 7mm (L x W x T)
Format: Paperback
Pages: 140
ISBN-13: 978-1-60692-817-2
Categories: Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Promotions
LSN: 1-60692-817-1
Barcode: 9781606928172

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners